Episode Details
Back to Episodes
CFO Cash-Out Amid Relay Surge | Business and Finance News
Description
Relay Therapeutics CFO Thomas Catinazzo cashed in big—selling over 187K shares worth $3.18M after exercising stock options—but this move fits his established pattern, not a panic exit. Despite slashing his direct stake by 51%, he still holds nearly 177K shares and has unexercised options dangling like future paydays. The biotech’s stock has exploded 500% in a year, fueled by cutting-edge cancer and genetic therapies, even as the company burns cash. With a $4.3B market cap, Catinazzo’s exit is a cash grab, not a retreat—his fingers are still on the pulse of this soaring biotech.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/67121ab35d7ed4d2